Leonteq Securities’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Leonteq Securities's EDIT Position: Q3 2026 in Review
Leonteq Securities increased its Editas Medicine (EDIT) stake by 105% in Q3 2026, buying an estimated $4.33K and bringing the position to 2,888 shares worth $7.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1046.
Leonteq Securities first reported a position in EDIT in Q3 2021 and has held it in 11 quarters since. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Leonteq Securities held 2,888 shares of Editas Medicine worth $7.42K as of Q3 2026.
- Leonteq Securities bought 1,479 Editas Medicine shares in Q3 2026, an estimated $4.33K.
- Editas Medicine made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1046 holding.
- Leonteq Securities first reported a position in Editas Medicine in Q3 2021 and has held it in 11 quarters since.
- 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.